[Association between TGF-Beta1 in allograft and chronic allograft nephropathy]. 2006

Ping-xian Wang, and Ming-qi Fan, and Gui-zhi Gong, and Hua-ying Xu, and Chi-bing Huang, and Gen-tu Zhang
Department of Urology, The Second Affiliated Hospital, Third Military Medical University, Chongqing 400037, China.

OBJECTIVE To investigate the relation between TGF-beta1 in allograft and chronic allograft nephropathy (CAN). METHODS The levels of urine TGF-beta1 were tested in 146 recipients whose renal function were normal from September 1, 2000 to January 31, 2001. Twenty recipients with the highest level of urine TGF-beta1 were classified in group A, while 20 other recipients with the lowest level of urine TGF-beta1 were classified in group B. In these two groups biopsies were carried out in 14 cases and 12 cases respectively, and TGF-beta1 mRNA in the biopsies was measured by RT-PCR. The levels of TGF-beta1 in the blood were also measured in the two groups. Three years later, the renal function was compared between the two groups. Biopsies were carried out in renal recipients whose creatinine is higher than normal. RESULTS The level of TGF-beta1 in the blood showed no significant difference between the two groups; 3 years after transplantation, the loss of renal function in group A was severer than that in group B. The number levels of CAN cases in group A was larger than that in group B. The expression levels of TGF-beta1 and TGF-beta1 mRNA of the allografts were higher in group A than in group B; there were statistically significant differences between the two groups. CONCLUSIONS The findings suggest that there is an association between TGF-beta1 in kidneys and CAN. The level of urine TGF-beta1 after renal transplantation may predict future renal function.

UI MeSH Term Description Entries
D007676 Kidney Failure, Chronic The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION. ESRD,End-Stage Renal Disease,Renal Disease, End-Stage,Renal Failure, Chronic,Renal Failure, End-Stage,Chronic Kidney Failure,End-Stage Kidney Disease,Chronic Renal Failure,Disease, End-Stage Kidney,Disease, End-Stage Renal,End Stage Kidney Disease,End Stage Renal Disease,End-Stage Renal Failure,Kidney Disease, End-Stage,Renal Disease, End Stage,Renal Failure, End Stage
D008297 Male Males
D011237 Predictive Value of Tests In screening and diagnostic tests, the probability that a person with a positive test is a true positive (i.e., has the disease), is referred to as the predictive value of a positive test; whereas, the predictive value of a negative test is the probability that the person with a negative test does not have the disease. Predictive value is related to the sensitivity and specificity of the test. Negative Predictive Value,Positive Predictive Value,Predictive Value Of Test,Predictive Values Of Tests,Negative Predictive Values,Positive Predictive Values,Predictive Value, Negative,Predictive Value, Positive
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012333 RNA, Messenger RNA sequences that serve as templates for protein synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic mRNA is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for certain, but it may play a role in the export of mature mRNA from the nucleus as well as in helping stabilize some mRNA molecules by retarding their degradation in the cytoplasm. Messenger RNA,Messenger RNA, Polyadenylated,Poly(A) Tail,Poly(A)+ RNA,Poly(A)+ mRNA,RNA, Messenger, Polyadenylated,RNA, Polyadenylated,mRNA,mRNA, Non-Polyadenylated,mRNA, Polyadenylated,Non-Polyadenylated mRNA,Poly(A) RNA,Polyadenylated mRNA,Non Polyadenylated mRNA,Polyadenylated Messenger RNA,Polyadenylated RNA,RNA, Polyadenylated Messenger,mRNA, Non Polyadenylated
D016030 Kidney Transplantation The transference of a kidney from one human or animal to another. Grafting, Kidney,Renal Transplantation,Transplantation, Kidney,Transplantation, Renal,Kidney Grafting,Kidney Transplantations,Renal Transplantations,Transplantations, Kidney,Transplantations, Renal
D053773 Transforming Growth Factor beta1 A subtype of transforming growth factor beta that is synthesized by a wide variety of cells. It is synthesized as a precursor molecule that is cleaved to form mature TGF-beta 1 and TGF-beta1 latency-associated peptide. The association of the cleavage products results in the formation a latent protein which must be activated to bind its receptor. Defects in the gene that encodes TGF-beta1 are the cause of CAMURATI-ENGELMANN SYNDROME. TGF-beta1,Transforming Growth Factor-beta1,TGF-beta-1,TGF-beta1 Latency-Associated Protein,TGF-beta1LAP,Transforming Growth Factor beta 1 Latency Associated Peptide,Transforming Growth Factor beta I,Latency-Associated Protein, TGF-beta1,TGF beta 1,TGF beta1 Latency Associated Protein,TGF beta1LAP
D020133 Reverse Transcriptase Polymerase Chain Reaction A variation of the PCR technique in which cDNA is made from RNA via reverse transcription. The resultant cDNA is then amplified using standard PCR protocols. Polymerase Chain Reaction, Reverse Transcriptase,Reverse Transcriptase PCR,PCR, Reverse Transcriptase,Transcriptase PCR, Reverse

Related Publications

Ping-xian Wang, and Ming-qi Fan, and Gui-zhi Gong, and Hua-ying Xu, and Chi-bing Huang, and Gen-tu Zhang
January 2007, Journal of nephrology,
Ping-xian Wang, and Ming-qi Fan, and Gui-zhi Gong, and Hua-ying Xu, and Chi-bing Huang, and Gen-tu Zhang
January 2003, Physiological research,
Ping-xian Wang, and Ming-qi Fan, and Gui-zhi Gong, and Hua-ying Xu, and Chi-bing Huang, and Gen-tu Zhang
August 1999, Kidney international,
Ping-xian Wang, and Ming-qi Fan, and Gui-zhi Gong, and Hua-ying Xu, and Chi-bing Huang, and Gen-tu Zhang
May 2006, Kidney international,
Ping-xian Wang, and Ming-qi Fan, and Gui-zhi Gong, and Hua-ying Xu, and Chi-bing Huang, and Gen-tu Zhang
January 1999, Annals of transplantation,
Ping-xian Wang, and Ming-qi Fan, and Gui-zhi Gong, and Hua-ying Xu, and Chi-bing Huang, and Gen-tu Zhang
January 2004, Journal of nephrology,
Ping-xian Wang, and Ming-qi Fan, and Gui-zhi Gong, and Hua-ying Xu, and Chi-bing Huang, and Gen-tu Zhang
April 2007, Nan fang yi ke da xue xue bao = Journal of Southern Medical University,
Ping-xian Wang, and Ming-qi Fan, and Gui-zhi Gong, and Hua-ying Xu, and Chi-bing Huang, and Gen-tu Zhang
September 2006, Iranian journal of allergy, asthma, and immunology,
Ping-xian Wang, and Ming-qi Fan, and Gui-zhi Gong, and Hua-ying Xu, and Chi-bing Huang, and Gen-tu Zhang
January 2001, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association,
Ping-xian Wang, and Ming-qi Fan, and Gui-zhi Gong, and Hua-ying Xu, and Chi-bing Huang, and Gen-tu Zhang
December 2017, Experimental and therapeutic medicine,
Copied contents to your clipboard!